Leukoreduction Filters in Transfusion Medicine: 4 Factors That Matter Most
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, has shared a post on LinkedIn:
”Do all leukoreduction filters perform the same? Not really…
In transfusion medicine, not all filters are equal. Behind what looks like a simple device lie technical choices that directly impact patient safety and blood product quality. So… how do you know which one is the right filter?
Here are the 4 key criteria:
Leukoreduction performance
• European standard: ≤ 1 million residual white blood cells
• AABB standard: ≤ 5 million
In practice, users often expect a filter to perform 5 to 10 times better than these limits, to ensure stability and safety.
Residual losses
An efficient filter retains leukocytes… but it may also trap red blood cells. Too much loss = a direct impact on hemoglobin levels, or on the required minimum recovery (≥ 85% according to AABB). The challenge is to find the right balance.
Filtration speed
Some centers want ultra-fast processing. Others prefer quality over speed. It all depends on the number of units to process daily and the available “masked time.”
Final component quality
Filters also influence hemolysis in red blood cells or platelet activation in PC. An invisible variable… but one that determines therapeutic value.
Conclusion – there is no such thing as a “perfect” filter. The right filter is the one that fits your process, your priorities, and your patients.
And you, which of these criteria weighs the most in your decisions?”
Stay updated on the emerging in transfusion medicine with Hemostasis Today.
-
Sep 2, 2025, 13:59No Added Benefit of Surgery Within 72 Hours for Intracerebral Hemorrhage
-
Sep 2, 2025, 13:57DCB Technical Mastery Webinar by SCAI: European Best Practices for Complex Coronary Lesions
-
Sep 2, 2025, 13:51Zack Wheeler’s DVT Diagnosis Highlights Thoracic Outlet Syndrome Risks in Athletes: National Blood Clot Alliance
-
Sep 2, 2025, 13:39Heparins Outperform DOACs and FXII/FXI Inhibitors in Preventing Thrombin Generation: JTH Study
-
Sep 2, 2025, 08:51Perioperative Direct Oral Anticoagulant (DOAC) Dosing: Insights Dr. Sthanu Subramanian
-
Sep 3, 2025, 14:17Ron Blankstein Unlocks the Secrets to Healthy Vascular Aging and Atherosclerosis Imaging
-
Sep 3, 2025, 14:13Pulmonary Thromboembolism Explained: From Virchow’s Triad to Imaging, Treatment, and Complications
-
Sep 3, 2025, 12:48Richa Sharma Shares ARCADIA Post-Hoc Findings: Apixaban Prevents Recurrent Stroke in ESUS Patients with LV Dysfunction
-
Sep 2, 2025, 13:55Nirav Dhanesha and LSU Health Shreveport Team Discover Neutrophil Integrin α9 as a Key Target in Subarachnoid Hemorrhage Recovery
-
Sep 2, 2025, 13:42Torsten Tonn Highlights Breakthrough in Blood Pharming: miRNA-30a-5p Knockout Restores Red Cell Differentiation
-
Sep 2, 2025, 13:53Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
-
Sep 2, 2025, 13:04Ischemic Stroke or TIA Linked to Higher Femoral Fracture Risk
-
Sep 2, 2025, 12:51Treatment of Deep Brain AVMs Tied to Increased Hemorrhagic Stroke Risk
-
Aug 29, 2025, 09:03Vasculearn Network: New 2025 High Blood Pressure Guidelines Are Here
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Sep 3, 2025, 14:18Living with Factor V Deficiency: Helen’s Inspiring Story on Haemnet Haemcast
-
Sep 3, 2025, 14:11Leukoreduction Filters in Transfusion Medicine: 4 Factors That Matter Most
-
Sep 3, 2025, 14:00Jacek Lesinski: The Importance of Whole Blood and Plasma Donation
-
Sep 2, 2025, 14:02King Felipe VI Highlights Global Challenge of Cardiovascular Health at ESC Congress 2025
-
Sep 1, 2025, 08:09Wafik S. El-Deiry Opens Up on Recovery, Gratitude, and Book After Life-Changing Heart Surgery